Scholar Rock is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and anemia.Read more
Merck is one of Scholar Rock's top rivals. Merck is a Public company that was founded in 1891 in Kenilworth, New Jersey. Like Scholar Rock, Merck also works within the Biotechnology industry. Compared to Scholar Rock, Merck has 73,935 more employees.
Sanofi is seen as one of Scholar Rock's biggest rivals. Sanofi was founded in 1994 in Paris, Île-de-France. Sanofi competes in the Pharmaceuticals industry. Sanofi generates $44.4B more revenue than Scholar Rock.
Scholar Rock's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 8.8B. Over the last four quarters, Scholar Rock's revenue has grown by 20.7%. Specifically, in Q1 2021's revenue was $4.7M; in Q4 2020, it was $3.4M; in Q3 2020, it was $3M; in Q2 2020, Scholar Rock's revenue was $3.9M.
No recent acquisitions found related to Scholar Rock
No recent investments found related to Scholar Rock